iECURE
Blood & Organ Banks · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
620 W Germantown Pike Ste 220, Plymouth ...Phone Number
(267) 817-4800Website
www.iecure.comRevenue
<$5 MillionIndustry
About iECURE
iECURE is focused on advancing innovative genetic therapies aimed at treating rare neurometabolic disorders through in vivo gene editing. Their targeted gene insertion approach seeks to restore the function of dysfunctional genes, particularly for conditions with limited treatment options. The company is dedicated to providing potentially curative therapies for patients suffering from devastating rare diseases, with an emphasis on long-term disease control. iECURE's programs primarily target urea cycle disorders, addressing significant unmet medical needs in this area.Explore more
iECURE Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to iECURE
Compare insights from companies similar to iECURE, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
iECURE Tech Stack
A closer look at the technologies used by iECURE
See more technologies
Top Blood & Organ Banks Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding iECURE
Sign Up For FreeTo access detailed company insights
iECURE is focused on advancing innovative genetic therapies aimed at treating rare neurometabolic disorders through in vivo gene editing. Their targeted gene insertion approach seeks to restore the function of dysfunctional genes, particularly for conditions with limited treatment options. The company is dedicated to providing potentially curative... Read More
